Early Clinical Evidence (Small but Promising) A 2025 case series followed five women with lipedema and insulin resistance treated with the GLP-1 medication exenatide (Patton et al., 2025)
Researchers noted some positive effects of the supplement on blood sugar, but it was not always statistically significant
We need large-scale, long-duration trials with direct muscle function measurements to draw firm conclusions across broader patient populations, including those with sarcopenia, cachexia, or heart disease
We do not condone or encourage consumer use of research compounds
Common side effects of Victoza include nausea, diarrhea, vomiting, decreased appetite, indigestion, and/or constipation